Related Experiment Video
Updated: Jul 5, 2025

06:26
Novel and Innovative Hybrid Technique for Type A Aortic Dissection
Published on: March 28, 2025
291
An early single-center experience with the Relay double inner-branch arch endograft
Cristóbal Iglesias Iglesias1, Carmen González Canga1, Francisco Abril Ramiro1
1Department of Vascular Surgery, Hospital Universitario Central de Asturias (HUCA), Oviedo, Spain.
Journal of Thoracic Disease
|January 22, 2024
Summary
Endovascular repair of aortic arch pathologies using a double inner-branched endograft is feasible for high-risk patients. Early outcomes show promising survival rates, but minimizing neurological complications is crucial for long-term success.
Area of Science:
- Cardiovascular Surgery
- Endovascular Interventions
- Aortic Disease Management
Background:
- Open surgery is the standard for aortic arch pathologies.
- Endovascular techniques offer an alternative for patients unfit for open repair.
- This study evaluates early outcomes of a specific endovascular device for aortic arch repair.
Purpose of the Study:
- To assess the early outcomes of patients treated with a double inner-branched arch endograft.
- To evaluate the feasibility and safety of this endovascular technique in a tertiary-care setting.
- To identify early complications and survival rates in a high-risk patient cohort.
Main Methods:
- Prospective analysis of consecutive elective endovascular arch repairs from 2016-2022.
- Use of a custom-made Relay double inner-branched endograft with associated extra-anatomical bypass.
- Analysis of comorbidities, periprocedural data, immediate results, and follow-up complications.
Main Results:
- 100% technical success in 12 high-risk patients (mean age 74, 100% male).
- Early complications included respiratory insufficiency (25%), stroke (8.3%), and perioperative death (8.3%).
- Median follow-up of 15.5 months showed 17% overall mortality and 100% aortic-related death-free survival at 2 years.
Conclusions:
- Endovascular treatment of aortic arch pathology is feasible in high-risk patients.
- Promising early mortality and stroke rates were observed.
- Minimizing neurological complications and longer follow-up are essential to determine long-term effectiveness and device-related issues.

